Developing a faster and cheaper method for retinal imaging using advanced technology
High-Speed, Low-Cost, Image Remapping Spectral Domain Full-Field Optical Coherence Tomography for Retinal Imaging
This study is working on a new way to take pictures of the retina that is faster and cheaper, so more people, especially in rural areas, can get the eye care they need to catch problems early.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-10851922 on NIH RePORTER |
What this research studies
This research focuses on improving Optical Coherence Tomography (OCT), a technique used for imaging the retina, by creating a new system that captures images more quickly and at a lower cost. The approach involves using advanced manufacturing techniques and high-resolution cameras to enhance image quality and stability, making it suitable for use in various healthcare settings, including rural and underserved areas. By addressing the limitations of current OCT systems, this research aims to make retinal imaging more accessible and effective for early diagnosis of retinal diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for retinal diseases, particularly those in underserved or rural areas where access to current imaging technology is limited.
Not a fit: Patients who do not have retinal diseases or those who already have access to advanced imaging technologies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accessible and affordable retinal imaging, improving early diagnosis and treatment of retinal diseases for many patients.
How similar studies have performed: Previous research has shown promise in improving imaging techniques for retinal diagnostics, suggesting that this approach could also yield significant advancements.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Applegate, Brian E. — University of Southern California
- Study coordinator: Applegate, Brian E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.